Quick Takeaways
- This page summarizes Manher Joshi's Form 3 filing for SOLENO THERAPEUTICS INC (SLNO).
- 0 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 12 Nov 2025, 17:19.
Manher Joshi - 10 Nov 2025 Form 3 Insider Report for SOLENO THERAPEUTICS INC (SLNO)
- Signature
- /s/ Anish Bhatnagar, Attorney-in-Fact
- Issuer symbol
- SLNO
- Transactions as of
- 10 Nov 2025
- Net transactions value
- $0
- Form type
- 3
- Filing time
- 12 Nov 2025, 17:19:11 UTC
- Previous filing
- 20 Nov 2023
- Next filing
- 23 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Manher Joshi filed Form 3 for SOLENO THERAPEUTICS INC (SLNO) on 12 Nov 2025."
What Changed
- Previous filing in this sequence was filed on 20 Nov 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Joshi Manher | Chief Development Officer | 100 MARINE PARKWAY, SUITE 400, REDWOOD CITY | /s/ Anish Bhatnagar, Attorney-in-Fact | 12 Nov 2025 | 0001978048 |
No securities are beneficially owned.
Remarks:
Exhibit 24 - Power of Attorney